Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma.
Hidenari NagaiMakoto AmanumaTakanori MukozuKojiro KobayashiHideki NagumoKunihide MohriGo WatanabeNaoyuki YoshimineYu OginoYasuko DaidoYasushi MatsukiyoTeppei MatsuiNoritaka WakuiKoichi MomiyamaKoji HigaiTakahisa MatsudaYoshinori IgarashiPublished in: Oncology (2023)
In patients with HCC, LEN decreases serum levels of carnitine, skeletal muscle volume, and worsens cardiac function.